About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Expert Opinion on Drug Delivery
›
top-articles
Expert Opinion on Drug Delivery
5.9
(top 5%)
impact factor
1.9K
(top 10%)
papers
95.9K
(top 5%)
citations
130
(top 5%)
h
-index
6.4
(top 5%)
impact factor
2.2K
all documents
100.2K
doc citations
194
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications
Expert Opinion on Drug Delivery
2010
975
2
Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems
Expert Opinion on Drug Delivery
2010
917
3
Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications
Expert Opinion on Drug Delivery
2016
674
4
Cyclodextrins in drug delivery
Expert Opinion on Drug Delivery
2005
640
5
Ultrasonic drug delivery – a general review
Expert Opinion on Drug Delivery
2004
518
6
Overcoming the barriers in micellar drug delivery: loading efficiency,
in vivo
stability, and micelle–cell interaction
Expert Opinion on Drug Delivery
2010
487
7
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Expert Opinion on Drug Delivery
2012
465
8
The importance of nanoparticle shape in cancer drug delivery
Expert Opinion on Drug Delivery
2015
455
9
Drug delivery strategies for poorly water-soluble drugs
Expert Opinion on Drug Delivery
2007
448
10
Gold nanoparticles: opportunities and challenges in nanomedicine
Expert Opinion on Drug Delivery
2010
437
11
Polymeric micelles for drug delivery
Expert Opinion on Drug Delivery
2006
369
12
Nanoparticles for biomedical imaging
Expert Opinion on Drug Delivery
2009
369
13
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Expert Opinion on Drug Delivery
2019
364
14
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
Expert Opinion on Drug Delivery
2014
357
15
CSF, blood-brain barrier, and brain drug delivery
Expert Opinion on Drug Delivery
2016
356
16
Direct nose to brain drug delivery
via
integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting
Expert Opinion on Drug Delivery
2013
342
17
Eudragit®: a technology evaluation
Expert Opinion on Drug Delivery
2013
341
18
Metal-organic frameworks as potential drug delivery systems
Expert Opinion on Drug Delivery
2013
325
19
Drug delivery by red blood cells: vascular carriers designed by mother nature
Expert Opinion on Drug Delivery
2010
323
20
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
Expert Opinion on Drug Delivery
2006
317
21
PEG-modified biopharmaceuticals
Expert Opinion on Drug Delivery
2009
316
22
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
Expert Opinion on Drug Delivery
2011
299
23
Albumin and its application in drug delivery
Expert Opinion on Drug Delivery
2015
298
24
Targeted drug delivery via folate receptors
Expert Opinion on Drug Delivery
2008
296
25
Advances in PEGylation of important biotech molecules: delivery aspects
Expert Opinion on Drug Delivery
2008
283
26
Advances in orodispersible films for drug delivery
Expert Opinion on Drug Delivery
2011
278
27
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Expert Opinion on Drug Delivery
2012
277
28
Cell-mediated drug delivery
Expert Opinion on Drug Delivery
2011
274
29
Albumin nanostructures as advanced drug delivery systems
Expert Opinion on Drug Delivery
2016
271
30
Ocular drug delivery
Expert Opinion on Drug Delivery
2006
267
31
Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
Expert Opinion on Drug Delivery
2009
263
32
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers
Expert Opinion on Drug Delivery
2010
263
33
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Expert Opinion on Drug Delivery
2017
261
34
Skin permeabilization for transdermal drug delivery: recent advances and future prospects
Expert Opinion on Drug Delivery
2014
260
35
Therapeutic applications of hydrogels in oral drug delivery
Expert Opinion on Drug Delivery
2014
259
36
Mannose-targeted systems for the delivery of therapeutics
Expert Opinion on Drug Delivery
2008
255
37
Layered double hydroxide nanoparticles in gene and drug delivery
Expert Opinion on Drug Delivery
2009
255
38
pH- and ion-sensitive polymers for drug delivery
Expert Opinion on Drug Delivery
2013
251
39
Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration
Expert Opinion on Drug Delivery
2007
248
40
Silk fibroin biomaterials for controlled release drug delivery
Expert Opinion on Drug Delivery
2011
248
41
Nanoparticle–aptamer bioconjugates for cancer targeting
Expert Opinion on Drug Delivery
2006
245
42
Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased
in vivo
activity
Expert Opinion on Drug Delivery
2011
243
43
Ocular novel drug delivery: impacts of membranes and barriers
Expert Opinion on Drug Delivery
2008
239
44
Drug delivery from gelatin-based systems
Expert Opinion on Drug Delivery
2015
237
45
Liposomal nanomedicines
Expert Opinion on Drug Delivery
2008
235
46
Magnetic targeting for site-specific drug delivery: applications and clinical potential
Expert Opinion on Drug Delivery
2009
235
47
Cationic liposomes for gene delivery
Expert Opinion on Drug Delivery
2005
234
48
Dry powder inhalers for pulmonary drug delivery
Expert Opinion on Drug Delivery
2004
232
49
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Expert Opinion on Drug Delivery
2015
230
50
Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)
Expert Opinion on Drug Delivery
2007
224
site/software ©
exaly
; All materials licenced under
CC by-SA
.